News

Mira's Ultra4 Hormone Monitor Revolutionizes Home Health Testing

Mira's Ultra4 Hormone Monitor Revolutionizes Home Health Testing

Mira's Ultra4 Hormone Monitor: A Game Changer for Home Health

In an exciting leap forward for at-home health care, Mira has launched the Ultra4™ Hormone Monitor. This innovative device has garnered recognition as a CES Innovation Awards 2026 Honoree in Digital Health, illustrating its significant potential in the hormone health space.

What is the Ultra4 Hormone Monitor?

The Ultra4 Hormone Monitor stands alone in its ability to deliver lab-quality hormone testing from the comfort of home. This cutting-edge technology measures four crucial hormones — FSH, LH, E3G, and PdG — utilizing advanced fluorescent immunoassay technology.

Users can conduct a simple test that lasts only 16 minutes, providing insights that were previously attainable only through extensive bloodwork. This accessibility marks a strategic shift toward empowering individuals with real-time hormonal data, resulting in a deeper understanding of their health and well-being.

Consumer Demand and Feedback

Since its soft launch, the Ultra4 has undergone tens of thousands of tests, reflecting a growing demand for continuous hormone insights. Early feedback reveals that 91% of users better understood the root causes of various health issues such as fatigue, mood fluctuations, and cycles that are irregular. This level of informed self-care is a pivotal step toward personalized health management.

Data-Driven Insights into Hormonal Health

Mira's Hormone Intelligence™ Platform is underpinned by a robust database of over 30 million real-world hormone data points collected over a decade. Originally focused on fertility, Mira has expanded its vision to encompass broader health implications. Their findings show how hormones play a vital role in energy levels, emotional health, metabolism, and longevity.

The Future of At-Home Health Labs

With the Ultra4, Mira is determined to pioneer the concept of a comprehensive at-home health lab. This initiative aims to integrate testing of hormonal, metabolic, and biological signals across urine, blood, and saliva. By creating this holistic tool, Mira intends to enhance understanding and management of various health conditions, particularly those that disproportionately affect women.

Addressing Women's Health Needs

Despite women living longer, they often endure 25% more of their lives in poor health. Many of the chronic conditions they face are tied to hormonal and metabolic issues which remain complex and underexplored. Mira's advancements target these gaps, promoting a deeper awareness of women's health and hormonal balance.

Expertise Behind the Vision

Mira's CEO and co-founder, Sylvia Kang, expressed her passion for this field, stating, "We've spent nearly a decade collecting real-world hormonal data, totaling over 30 million data points. This extensive research underscores that hormones influence far beyond fertility; they are central to our feelings, functions, and aging process. The Ultra4 is a stepping stone toward a more expansive vision focused on proactive, personalized health."

Explore the Innovations at CES 2026

At the CES 2026 event, Mira plans to unveil its plans for the Ultra4 as part of a broader vision for managing longevity and chronic conditions. Attendees are encouraged to visit Mira at CES Booth #54298 to learn more about this revolutionary technology and engage with its leadership team.

Discover More About Mira

Mira is dedicated to enhancing understanding of hormonal health for women at every life stage, from menstruation and fertility to menopause and aging. Founded in 2015, the company is reimagining how hormonal data can influence health decisions in daily life. For more details, check out their website at miracare.com.

Frequently Asked Questions

What is the purpose of Mira's Ultra4 Hormone Monitor?

The Ultra4 Hormone Monitor provides lab-quality hormone testing at home, allowing users to gain insights into their hormonal health conveniently.

What hormones does the Ultra4 monitor measure?

The device measures FSH, LH, E3G, and PdG using advanced technology, offering users comprehensive insights into their hormonal status.

How user-friendly is the Ultra4 testing process?

The testing process is simple and quick, taking only 16 minutes to complete, which is significantly faster than traditional blood testing.

What feedback have users given about the Ultra4 Hormone Monitor?

Users have reported a 91% satisfaction rate, indicating a better understanding of their symptoms and health conditions after using the device.

What vision does Mira have for the future of home health?

Mira aims to build an integrated system that combines testing across multiple bodily fluids, providing a comprehensive understanding of health, particularly in women.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Midlife ADHD in Women: New Challenges and Solutions

Updated Category News Views 2

ADHD Evolution in Women's Midlife They say change is the only constant, and boy, does that ring true for women navigating the turbulent seas of ADHD as they hit 40 and beyond. According to Germaine Swanson, the ADHD landscape changes dramatically in midlife, especially for women. We're talking about a mix of hormonal shifts, increasing life demands, and changes in brain...

Continue Reading
Global Communication Works Opens SignlLabs™ AI Licensing

Updated Category News Views 30

AI Signaling Moves Beyond GCW's Own Clients Remember when we first looked at GCW's SignlLabs and the idea of helping brands show up inside ChatGPT, Gemini, Claude, Copilot and Perplexity? Well, Global Communication Works is taking the next step. Instead of keeping its AI Signaling playbook inside the agency walls, GCW is now opening SignlLabs up for licensing

Continue Reading
Cove Capital Secures $9.96M for Debt-Free Logistics DST

Updated Category News Views 1

Unpacking Cove Capital's Latest Victory Cove Capital Investments has pulled off another coup, raising a hefty $9,964,510 for its Cove Essential Net Lease Industrial 108 DST. It's a Regulation D, Rule 506(c) offering, now fully subscribed, spotlighting a debt-free investment ethos and a rock-solid logistics site in Anchorage, Alaska. Strategic Facility Anchoring Investment...

Continue Reading
Wave Kids™ Unveils New Flavors for Kids' Drinks

Updated Category News Views 1

Sparking a Fresh Wave in the Kids' Beverage Market Alright, let me tell you about a new player plowing into the kids' drink scene. Wave Kids™, a brand that's making waves—pun intended—has a fresh lineup that screams 'fun' and 'healthy' in equal measure. Just coinciding with back-to-school season, this Scottsdale, Arizona outfit has rolled out not one or two, but...

Continue Reading
Cap Juluca: Caribbean Luxury Redefined on Maundays Bay

Updated Category News Views 0

The Tranquil Call of Maundays Bay Find me dipping my toes in the sands of Maundays Bay come October 10, 2026, and you'll understand why this slice of Anguilla stakes its claim to being the best beach on the globe. Cap Juluca, that crown jewel of Caribbean luxury, swings open its doors once more, promising indulgence framed by turquoise waters and the soft whisper of white...

Continue Reading
LeoLabs and SciTec Partner for $93.7M Space Force Deal

Updated Category News Views 1

LeoLabs and SciTec Join Forces for Space Dominance The space race ain't just about rockets blasting off anymore. It's about making sure we've got eyes everywhere, even on the back of our heads, so to speak. Enter LeoLabs teaming up with SciTec to help the U.S. Space Force upgrade their radar systems to something out of a sci-fi flick, armed with a $93.7 million contract...

Continue Reading
Woodpack Global Unveils Crate Design System: A New Era Begins

Updated Category News Views 1

Innovating the Wooden Crate Landscape An old industry got a much-needed facelift today, folks. Woodpack Global has rolled out Crate Design System™ (CDS)—a snazzy new tool that's shaking up the wooden crate design landscape. It blows the dust off outdated design methods that have been collecting cobwebs since the '60s. That's right, we’re talking about a significant...

Continue Reading
Sacrifice Unending: 9/11's Lingering Health Toll

Updated Category News Views 0

The Unseen Toll of 9/11 on the Firefighter Community Two and a half decades since that fateful morning of September 11, 2001, we're staring at a grim reality. The heroic souls of the New York City Fire Department (FDNY)—those who ran toward peril when others ran away—are still paying the price. Incredibly, more than 400 FDNY members have succumbed to World Trade...

Continue Reading
Fresh Thyme Empowers Local Brands in Michigan Debut

Updated Category News Views 2

A Community-Driven Retail Innovation The grocery game just got a little more personal in Michigan, and we're not talking about run-of-the-mill retail pitches. Fresh Thyme Market, known for its commitment to local and natural products, is shaking things up with their Pitch Thyme Competition. This ain’t your usual product presentation. It’s a whole new ball game where...

Continue Reading
ZEEKR's Shooting Brakes Dominate: Over 400K Sold

Updated Category News Views 3

ZEEKR's Stellar Performance in a Crowded Market Another month, another bumper crop for ZEEKR's shooting brakes. These beauties aren't just hanging in there; they're leading the pack. In August alone, global deliveries marched past the 10,000 mark for the third month running—a feat not easily achieved in today's saturated automotive landscape. It's no wonder the...

Continue Reading

Top 5 Most Recently Viewed Articles

Phathom Pharmaceuticals Engages at Upcoming Biotech Conference

Updated Category News Views 97

Phathom Pharmaceuticals to Present at Biotech Conference Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company dedicated to creating innovative treatments for gastrointestinal (GI) disorders, is set to feature at the Guggenheim Securities SMID Cap Biotech Conference. This event is anticipated to be a critical platform for discussions around novel...

Continue Reading
Bumble's Future: Is Acquisition on the Horizon as Analysts Speculate?

Updated Category News Views 119

Bumble's Acquisition Potential Analyzed Recent evaluations from analysts have sparked discussions about the future of Bumble Inc. (BMBL) and its position in the online dating market. KeyBanc Capital Markets analyst Justin Patterson has initiated attention by downgrading Bumble’s stock from Overweight to Sector Weight. This change reflects growing concerns regarding...

Continue Reading
Promising Progress of VE303 in Fighting rCDI Proves Hopeful

Updated Category News Views 241

Promising Advances in rCDI Treatment with VE303 Vedanta Biosciences has unveiled exciting findings regarding its leading drug candidate, VE303, aimed at combating recurrent Clostridioides difficile infection (rCDI). The promising outcomes are from the recent Phase 2 study, known as CONSORTIUM, published in the reputable journal Nature Medicine. This trial demonstrated...

Continue Reading
Alamar Biosciences Unveils Revolutionary Assay for Alzheimer's Research

Updated Category News Views 196

Introduction to the NULISAqpcr BD-pTau217 Assay Alamar Biosciences has made a significant advancement in Alzheimer's disease research with the launch of the NULISAqpcr BD-pTau217 Assay, a non-invasive tool designed to detect brain-specific biomarkers. This innovative assay promises to enhance the sensitivity and specificity needed for robust neurodegenerative studies and...

Continue Reading
Exxon Mobil: Strong Q3 Performance with Rising Revenues and Dividends

Updated Category News Views 70

Exxon Mobil's Impressive Q3 Earnings Report Exxon Mobil Corporation (NYSE: XOM) recently announced its third-quarter earnings, showcasing strong financial performance that has led to a rise in its stock value. The company reported total revenues and other income of $90.016 billion, which, while below the expected consensus of $93.938 billion, still reflects the...

Continue Reading